AI assistant
BIOGEN INC. — Director's Dealing 2015
Mar 3, 2015
30291_dirs_2015-03-03_342d5f00-a960-4bc6-a090-cbaff76fd62f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOGEN IDEC INC. (BIIB)
CIK: 0000875045
Period of Report: 2015-03-01
Reporting Person: Sandrock Alfred (Grp SVP, Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-03-01 | Common Stock | F | 2826 | $409.59 | Disposed | 12178 | Direct |
| 2015-03-02 | Common Stock | S | 100 | $406.40 | Disposed | 12078 | Direct |
| 2015-03-02 | Common Stock | S | 1100 | $407.948 | Disposed | 10978 | Direct |
| 2015-03-02 | Common Stock | S | 600 | $408.98 | Disposed | 10378 | Direct |
| 2015-03-02 | Common Stock | S | 374 | $410.572 | Disposed | 10004 | Direct |
| 2015-03-02 | Common Stock | S | 1000 | $411.39 | Disposed | 9004 | Direct |
Footnotes
F1: Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
F2: Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
F3: This represents the weighted average price for shares sold at a range between $407.52 (low) and $408.26 (high).
F4: This represents the weighted average price for shares sold at a range between $408.76 (low) and $409.36 (high).
F5: This represents the weighted average price for shares sold at a range between $410.34 (low) and $410.98 (high).